|
Volumn 7, Issue 1, 2019, Pages 104-112
|
One-month zero-order sustained release and tumor eradication after a single subcutaneous injection of interferon alpha fused with a body-temperature-responsive polypeptide
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTICS;
ANTIBODIES;
GLYCOPROTEINS;
PHYSIOLOGY;
ADVERSE SIDE EFFECTS;
CIRCULATION HALF-LIFES;
INTERFERON ALPHAS;
PATIENT COMPLIANCE;
THERAPEUTIC EFFICACY;
THERAPEUTIC PROTEIN;
THERMO-RESPONSIVE;
TUMOR ACCUMULATION;
TUMORS;
ALPHA INTERFERON;
FUSION PROTEIN;
PEPTIDE;
ADMINISTRATION AND DOSAGE;
ANIMAL;
BAGG ALBINO MOUSE;
BODY TEMPERATURE;
CHEMISTRY;
DELAYED RELEASE FORMULATION;
FEMALE;
NEOPLASM;
NUDE MOUSE;
PATHOLOGY;
PHARMACOKINETICS;
SUBCUTANEOUS DRUG ADMINISTRATION;
ANIMALS;
BODY TEMPERATURE;
DELAYED-ACTION PREPARATIONS;
FEMALE;
INJECTIONS, SUBCUTANEOUS;
INTERFERON-ALPHA;
MICE, INBRED BALB C;
MICE, NUDE;
NEOPLASMS;
PEPTIDES;
RECOMBINANT FUSION PROTEINS;
|
EID: 85058758486
PISSN: 20474830
EISSN: 20474849
Source Type: Journal
DOI: 10.1039/c8bm01096j Document Type: Article |
Times cited : (21)
|
References (38)
|